Načítá se...
Role of CCL5 and CCR5 gene polymorphisms in EGFR signaling blockade in Metastatic Colorectal Cancer: Analysis of the FIRE-3 trial
BACKGROUND: Epidermal growth factor receptor signaling blockade increases CCL5 expression that regulate either the anti-tumor immune response or tumor progression. We investigated the potential role of CCL5/CCR5 axis in cetuximab-based treatment in metastatic colorectal cancer (mCRC) patients. PATIE...
Uloženo v:
| Vydáno v: | Eur J Cancer |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6367121/ https://ncbi.nlm.nih.gov/pubmed/30554073 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejca.2018.11.019 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|